Cargando…
Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers
OBJECTIVES: Leber’s hereditary optic neuropathy (LHON) is a mitochondrial genetic disease characterized by a variable and reduced penetrance. Individuals carrying a primary LHON-causing mitochondrial DNA (mtDNA) mutation may either remain asymptomatic lifelong, as unaffected carriers, or develop sud...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302380/ https://www.ncbi.nlm.nih.gov/pubmed/30572950 http://dx.doi.org/10.1186/s13104-018-4025-y |
_version_ | 1783381965364264960 |
---|---|
author | Bianco, Angelica Valletti, Alessio Longo, Giovanna Bisceglia, Luigi Montoya, Julio Emperador, Sonia Guerriero, Silvana Petruzzella, Vittoria |
author_facet | Bianco, Angelica Valletti, Alessio Longo, Giovanna Bisceglia, Luigi Montoya, Julio Emperador, Sonia Guerriero, Silvana Petruzzella, Vittoria |
author_sort | Bianco, Angelica |
collection | PubMed |
description | OBJECTIVES: Leber’s hereditary optic neuropathy (LHON) is a mitochondrial genetic disease characterized by a variable and reduced penetrance. Individuals carrying a primary LHON-causing mitochondrial DNA (mtDNA) mutation may either remain asymptomatic lifelong, as unaffected carriers, or develop sudden central visual loss that rapidly aggravates over some weeks. Over the years several genetic/environmental triggers able to modulate the risk of developing LHON have been proposed. We provided data supporting a possible correlation between LHON penetrance and the mtDNA copy number, a raw index of mitochondrial mass, whose increase could represent a compensatory response that cells implement to alleviate the pathogenic effect of the primary LHON-causing mtDNA mutations. DATA DESCRIPTION: We collected Italian and Spanish subjects harboring one of the three common LHON primary mutations, either in heteroplasmic or homoplasmic status. For each population we were able to discriminate between affected subjects presenting typical clinical tracts of LHON and LHON-causing mutation carriers showing no symptoms correlated with vision loss. Each subject has been characterized for the presence of a LHON primary mutation, for its status of homoplasmy or heteroplasmy, and for the mtDNA content per cell, expressed as relative mtDNA/nDNA ratio respect to controls. Additional clinical information is present for all the Italian subjects. |
format | Online Article Text |
id | pubmed-6302380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63023802018-12-31 Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers Bianco, Angelica Valletti, Alessio Longo, Giovanna Bisceglia, Luigi Montoya, Julio Emperador, Sonia Guerriero, Silvana Petruzzella, Vittoria BMC Res Notes Data Note OBJECTIVES: Leber’s hereditary optic neuropathy (LHON) is a mitochondrial genetic disease characterized by a variable and reduced penetrance. Individuals carrying a primary LHON-causing mitochondrial DNA (mtDNA) mutation may either remain asymptomatic lifelong, as unaffected carriers, or develop sudden central visual loss that rapidly aggravates over some weeks. Over the years several genetic/environmental triggers able to modulate the risk of developing LHON have been proposed. We provided data supporting a possible correlation between LHON penetrance and the mtDNA copy number, a raw index of mitochondrial mass, whose increase could represent a compensatory response that cells implement to alleviate the pathogenic effect of the primary LHON-causing mtDNA mutations. DATA DESCRIPTION: We collected Italian and Spanish subjects harboring one of the three common LHON primary mutations, either in heteroplasmic or homoplasmic status. For each population we were able to discriminate between affected subjects presenting typical clinical tracts of LHON and LHON-causing mutation carriers showing no symptoms correlated with vision loss. Each subject has been characterized for the presence of a LHON primary mutation, for its status of homoplasmy or heteroplasmy, and for the mtDNA content per cell, expressed as relative mtDNA/nDNA ratio respect to controls. Additional clinical information is present for all the Italian subjects. BioMed Central 2018-12-20 /pmc/articles/PMC6302380/ /pubmed/30572950 http://dx.doi.org/10.1186/s13104-018-4025-y Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Data Note Bianco, Angelica Valletti, Alessio Longo, Giovanna Bisceglia, Luigi Montoya, Julio Emperador, Sonia Guerriero, Silvana Petruzzella, Vittoria Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers |
title | Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers |
title_full | Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers |
title_fullStr | Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers |
title_full_unstemmed | Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers |
title_short | Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers |
title_sort | mitochondrial dna copy number in affected and unaffected lhon mutation carriers |
topic | Data Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302380/ https://www.ncbi.nlm.nih.gov/pubmed/30572950 http://dx.doi.org/10.1186/s13104-018-4025-y |
work_keys_str_mv | AT biancoangelica mitochondrialdnacopynumberinaffectedandunaffectedlhonmutationcarriers AT vallettialessio mitochondrialdnacopynumberinaffectedandunaffectedlhonmutationcarriers AT longogiovanna mitochondrialdnacopynumberinaffectedandunaffectedlhonmutationcarriers AT bisceglialuigi mitochondrialdnacopynumberinaffectedandunaffectedlhonmutationcarriers AT montoyajulio mitochondrialdnacopynumberinaffectedandunaffectedlhonmutationcarriers AT emperadorsonia mitochondrialdnacopynumberinaffectedandunaffectedlhonmutationcarriers AT guerrierosilvana mitochondrialdnacopynumberinaffectedandunaffectedlhonmutationcarriers AT petruzzellavittoria mitochondrialdnacopynumberinaffectedandunaffectedlhonmutationcarriers |